DE602004008242D1 - Nanopartikel für bioaffinitätstests - Google Patents

Nanopartikel für bioaffinitätstests

Info

Publication number
DE602004008242D1
DE602004008242D1 DE602004008242T DE602004008242T DE602004008242D1 DE 602004008242 D1 DE602004008242 D1 DE 602004008242D1 DE 602004008242 T DE602004008242 T DE 602004008242T DE 602004008242 T DE602004008242 T DE 602004008242T DE 602004008242 D1 DE602004008242 D1 DE 602004008242D1
Authority
DE
Germany
Prior art keywords
nanoparticle
particle
several
binding
shell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004008242T
Other languages
English (en)
Other versions
DE602004008242T2 (de
Inventor
Tero Soukka
Teemu Korpimaeki
Urpo Lamminmaeki
Marko Virta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Turku
Original Assignee
University of Turku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20030615A external-priority patent/FI20030615A0/fi
Application filed by University of Turku filed Critical University of Turku
Publication of DE602004008242D1 publication Critical patent/DE602004008242D1/de
Application granted granted Critical
Publication of DE602004008242T2 publication Critical patent/DE602004008242T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
DE602004008242T 2003-04-02 2004-04-02 Nanopartikel für bioaffinitätsassays Expired - Lifetime DE602004008242T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US45937403P 2003-04-02 2003-04-02
US459374P 2003-04-02
FI20030615 2003-04-24
FI20030615A FI20030615A0 (fi) 2003-04-24 2003-04-24 Nanopartikkeli bioaffiniteettimäärityksiin
PCT/FI2004/000204 WO2004088313A1 (en) 2003-04-02 2004-04-02 Nanoparticle for bioaffinity assays

Publications (2)

Publication Number Publication Date
DE602004008242D1 true DE602004008242D1 (de) 2007-09-27
DE602004008242T2 DE602004008242T2 (de) 2008-05-15

Family

ID=33133059

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004008242T Expired - Lifetime DE602004008242T2 (de) 2003-04-02 2004-04-02 Nanopartikel für bioaffinitätsassays

Country Status (6)

Country Link
US (1) US20110300558A1 (de)
EP (1) EP1608977B1 (de)
AT (1) ATE370413T1 (de)
DE (1) DE602004008242T2 (de)
ES (1) ES2293243T3 (de)
WO (1) WO2004088313A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070048383A1 (en) * 2005-08-25 2007-03-01 Helmus Michael N Self-assembled endovascular structures
GB0621894D0 (en) * 2006-11-02 2006-12-13 Iti Scotland Ltd Magnetic recognition system
CA2669951A1 (en) * 2006-12-04 2008-06-12 Innovative Purification Technologies Pty Ltd Protein particles
WO2008144817A1 (en) * 2007-05-30 2008-12-04 Innovative Purification Technologies Pty Ltd Fluorescent protein particles
CN101821622B (zh) * 2007-08-17 2015-04-08 韩国科学技术院 分子相互作用的检测方法
CN102608327A (zh) * 2012-03-01 2012-07-25 江苏省原子医学研究所 一种铁蛋白的示踪标记方法
KR101492167B1 (ko) * 2013-04-08 2015-02-10 한국과학기술연구원 페리틴 단백질을 함유하는 표적-특이적 프로브 및 이를 이용한 바이오마커의 탐지

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1308022C (en) * 1988-08-11 1992-09-29 Eleftherios P. Diamandis Multiple fluorescence labelling with europium chelators
JPH04507255A (ja) * 1989-08-18 1992-12-17 モンサント・カンパニー フェリチン類似物
EP1262489A1 (de) * 2001-05-14 2002-12-04 Matsushita Electric Industrial Co., Ltd. Komplex aus rekombinantem Ferritin und einem Edelmetall sowie dieses Ferritin kodierende DNA
ATE453669T1 (de) * 2002-05-10 2010-01-15 New Century Pharmaceuticals Ferritinfusionsproteine zur verwendung für impfstoffe und andere anwendungen

Also Published As

Publication number Publication date
EP1608977B1 (de) 2007-08-15
ATE370413T1 (de) 2007-09-15
ES2293243T3 (es) 2008-03-16
EP1608977A1 (de) 2005-12-28
WO2004088313A1 (en) 2004-10-14
US20110300558A1 (en) 2011-12-08
DE602004008242T2 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
WO2005095461A3 (en) Gold-binding protein and use thereof
WO2006034278A3 (en) Methods and compositions for detecting cancer using components of the u2 spliceosomal particle
HUP0303749A2 (hu) Veserák-specifikus tumormarkerek
EP2177614A3 (de) Zusammensetzung und Verfahren zur Diagnose von Speiseröhrenkrebs sowie der Metastasierung von Speiseröhrenkrebs
ATE541590T1 (de) Modifizierte antikörper-fragmente
DE60310032D1 (de) Kern-Mantel Nanoteilchen für (F) RET-Testverfahren
ATE446972T1 (de) Il-1 bindende antikörper und fragmente davon
WO2007061793A3 (en) Modified cardiolipin and uses therefor
WO2006119203A3 (en) Fluorescence lateral flow immunoassay
EP2154245A3 (de) Zusammensetzung und Verfahren zur Diagnose von Nierenkrebs und zur Vorhersage einer Prognose für einen Nierenkrebspatienten
DE602004019812D1 (de) Marker für neuromyelitis optica
CA2798562A1 (en) Methods and compositions for the diagnosis and treatment of thyroid cancer
WO2006116631A3 (en) Cancer specific pcna isoform binding antibodies and uses thereof
ATE370413T1 (de) Nanopartikel für bioaffinitätstests
DE602006018424D1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
WO2008029031A3 (fr) Test pharmaco diagnostique ciblant l' oncologie
WO2002027031A3 (en) Methods and reagents for live-cell gene expression quantification
WO2007076013A3 (en) Homocysteine immunoassay
WO2006099537A3 (en) The use of antibody-surrogate antigen systems for detection of analytes
DE60315343D1 (de) Neuartige verwendungen von durch ble-gene kodierten proteinen und antibiotika aus der bleomycin-familie
WO2006119264A3 (en) Antibodies against histone modifications for clinical diagnosis and prognosis of cancer
WO2006073563A3 (en) Fluorescent affinity tag to enhance phosphoprotein detection
WO2007060671A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2003017938A3 (en) Conjugates targeted to target receptors
DE60332479D1 (de) Holo-transcobalamin bindungspartner und ihre verwendung in cobalamintest

Legal Events

Date Code Title Description
8364 No opposition during term of opposition